Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Rosalind Advisors, Inc. is a life science investment firm based in Toronto, Canada, founded in 2006. The firm specializes in biotech funds and operates at the intersection of science and finance. Rosalind Advisors focuses on capitalizing on market inefficiencies within the biotechnology sector, managing a portfolio that reflects a deep understanding of the life sciences landscape.
Currently, Rosalind Advisors manages approximately $285 million in assets across 42 companies. The firm is recognized for its concentrated investments in public biotech securities, which allows it to navigate various stages of investment within the biotech field. This long-standing presence in the industry positions Rosalind as a knowledgeable player in the life sciences investment space.
Rosalind Advisors has established a reputation for its expertise in biotechnology, providing insights into market trends, regulatory landscapes, and clinical developments. The firm’s focus on public market investments enables it to identify unique opportunities within the biotech sector, making it a significant player in the life sciences investment community.
Rosalind Advisors primarily targets the life sciences sector, with a strong emphasis on biotechnology. The firm employs a market-agnostic investment strategy, allowing it to navigate various stages of investment, including Seed, Series A, and Series B rounds. This flexibility enables Rosalind to capitalize on market inefficiencies and arbitrage opportunities within the biotech industry.
Investment checks are not publicly disclosed, but the firm is known for its concentrated investments in public biotech securities. Rosalind Advisors focuses on companies that demonstrate potential for significant growth and innovation in the life sciences sector. The firm seeks to partner with founders who have a strong understanding of their market and a clear vision for their company's future.
Geographically, Rosalind Advisors concentrates its efforts in North America, particularly in Canada and the United States. The firm’s investment strategy is designed to exploit recurring market inefficiencies, making it a valuable partner for biotech companies looking to navigate the complexities of the public markets.
Rosalind Advisors has built a diverse portfolio of 42 companies, primarily in the biotechnology and healthcare sectors. Notable portfolio companies include:
This portfolio reflects Rosalind's commitment to investing in companies that are at the forefront of biotechnology and healthcare innovation. The firm’s concentrated approach allows it to provide significant support and resources to its portfolio companies, enhancing their potential for success in the competitive biotech landscape.
Gil Aharon — Co-founder of Rosalind Advisors, Gil holds a Ph.D. and has extensive experience in life sciences investment. He is recognized for his expertise in biotechnology and has played a key role in shaping the firm’s investment strategy.
Steven Salamon — Co-founder and President, Steven is a P.Eng. and CFA with a strong background in finance and investment management. His leadership has been instrumental in guiding Rosalind Advisors' focus on public biotech securities.
Ritchie Truong — Investment professional at Rosalind Advisors, Ritchie is a CFA and contributes to the firm’s investment analysis and decision-making processes.
Paridhi Goel — Another investment professional at Rosalind Advisors, Paridhi plays a role in evaluating potential investment opportunities within the biotech sector.
Thilaksi Chandrasekar — Investment professional at Rosalind Advisors, Thilaksi is involved in the firm’s investment activities and supports the analysis of biotech companies.
To pitch Rosalind Advisors, founders should visit their contact page at rosalindcap.com/contact-us. While specific pitch policies and check sizes are not disclosed, it is advisable to prepare a comprehensive pitch deck that outlines the unique aspects of your biotech venture. Founders should include information on market potential, competitive landscape, and the team’s expertise.
Response times and decision timelines are not publicly available, so founders should be prepared for varying timelines. A warm introduction may enhance the chances of engagement, but it is not explicitly required.
As of May 2026, Rosalind Advisors continues to actively manage its portfolio of public biotech securities, with a reported portfolio value of approximately $284.53 million across 42 assets. The firm has made significant investments in companies such as Replimune Group, Arrivent Biopharma, and Fennec Pharmaceuticals, reflecting its ongoing commitment to the biotechnology sector.
Recent filings indicate that Rosalind Advisors has been actively purchasing shares in various biotech firms, demonstrating its strategy of capitalizing on market inefficiencies. The firm’s focus on public market investments positions it well to identify unique opportunities in the rapidly evolving biotech landscape.
What are Rosalind Advisors' investment criteria?
Rosalind Advisors focuses on the life sciences sector, particularly biotechnology. The firm invests at various stages, including Seed, Series A, and Series B, and seeks companies that demonstrate significant growth potential and innovation.
How can I pitch to Rosalind Advisors?
Founders can contact Rosalind Advisors through their website at rosalindcap.com/contact-us. Specific pitch policies and check sizes are not publicly disclosed, so it is advisable to prepare a comprehensive pitch that highlights the unique aspects of your biotech venture.
What makes Rosalind Advisors different from other venture capital firms?
Rosalind Advisors specializes in biotechnology and life sciences investments, employing a market-agnostic strategy that allows them to capitalize on market inefficiencies. Their focus on public market investments distinguishes them from traditional venture capital firms.
What is the geographic focus of Rosalind Advisors?
The firm primarily invests in North America, with a strong emphasis on opportunities in Canada and the United States. This geographic focus allows them to leverage their expertise in the local biotech landscape.
What type of support does Rosalind Advisors provide to portfolio companies?
Rosalind Advisors adds value to its portfolio companies by leveraging its expertise in biotechnology and life sciences. The firm provides insights into market trends, regulatory landscapes, and clinical developments, helping companies navigate the complexities of the biotech sector.
What is the typical check size for investments made by Rosalind Advisors?
Check sizes are not publicly disclosed. However, the firm is known for its concentrated investments in public biotech securities, which may indicate a preference for significant investments in promising companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.